Are there socio-economic inequalities in the uptake of Down syndrome screening in the UK? by Prathapan S et al.
Newcastle University e-prints  
Date deposited:  22nd March 2013 
Version of file:  Submitted version 
Peer Review Status: Unknown 
Citation for item: 
Prathapan S, Adams J, Bythell M, Rankin J. Are there socio-economic inequalities in the uptake of 
Down syndrome screening in the UK?. Prenatal Diagnosis 2012, 32(3), 293-295. 
Further information on publisher website: 
http://onlinelibrary.wiley.com  
Publisher’s copyright statement: 
© 2012, Wiley-Blackwell 
This is the pre-peer reviewed version of the following article: Prathapan S, Adams J, Bythell M, Rankin 
J. Are there socio-economic inequalities in the uptake of Down syndrome screening in the 
UK?. Prenatal Diagnosis 2012, 32(3), 293-295, which has been published in final form at 
http://dx.doi.org/10.1002/pd.2927.  
The definitive version of this article is available at: 
http://dx.doi.org/10.1002/pd.2927 
Always use the definitive version when citing.   
Use Policy: 
The full-text may be used and/or reproduced and given to third parties in any format or medium, 
without prior permission or charge, for personal research or study, educational, or not for profit 
purposes provided that: 
 A full bibliographic reference is made to the original source 
 A link is made to the metadata record in Newcastle E-prints 
 The full text is not changed in any way. 
The full-text must not be sold in any format or medium without the formal permission of the 
copyright holders. 
 
 Robinson Library, University of Newcastle upon Tyne, Newcastle upon Tyne.  
NE1 7RU.  Tel. 0191 222 6000 
Inequalities in uptake of Down Syndrome screening 
 
1 
 
Are there socio-economic inequalities in the uptake of Down Syndrome screening in the 1 
UK? 2 
Shamini Prathapan1, Jean Adams1, Mary Bythell2, Judith Rankin1,2,* 3 
1Institute of Health & Society, Newcastle University, Baddiley-Clark Building, Richardson 4 
Road, Newcastle upon Tyne, NE2 4AX, UK 5 
2Regional Maternity Survey Office, 1-2 Claremont Road, Newcastle upon Tyne, NE2 4AE, UK 6 
*Author for correspondence: Judith.rankin@ncl.ac.uk; tel: 0191 222 8211; fax: 0191 222 7 
6043 8 
Main text word count: 1453; No. of tables: 1; No. of figures: 0 9 
Funding 10 
NorCAS is funded, and MB part-funded, by the Department of Health.  JR was funded by a 11 
Personal Award Scheme Career Scientist Award from the National Institute of Health 12 
Research (Department of Health) when this work was conducted.  JA is funded by Fuse – the 13 
Centre for Translational Research in Public Health, a UKCRC Public Health Research: Centre 14 
of Excellence.  Funding from the British Heart Foundation, Cancer Research UK, Economic 15 
and Social Research council, Medical Research Council, and the Department of Health, 16 
under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged.  17 
The funders had no involvement in any aspect of the research. 18 
Inequalities in uptake of Down Syndrome screening 
 
2 
 
Conflicts of interest 1 
None 2 
What’s already known about this topic? 3 
 There are socio-economic inequalities in the uptake of a number of screening 4 
programmes in the UK 5 
 Previous research, using maternal self-report , found little evidence of socio-economic 6 
inequalities in the uptake of Down Syndrome screening in the UK 7 
What this study adds 8 
 Using prospectively collected data we found no evidence of socio-economic inequalities 9 
in uptake of Down Syndrome screening in the UK 10 
11 
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In the UK, national guidelines state that Down syndrome screening involving nuchal 1 
translucency and/or serum tests should be offered to all pregnant women before 20 weeks 2 
gestation.  Recent data suggest that whilst around 90% of pregnant women are offered such 3 
screening, uptake may be much lower (Rowe et al., 2008).  The reasons for refusal of 4 
declining this screening of screening include negative attitudes towards the test, negative 5 
attitudes towards termination of pregnancy, and willingness to keep the fetus whether or 6 
not Down syndrome is diagnosed (Kuppermann et al., 2006, Li et al., 2008). 7 
Previous research has found strong socio-economic gradients in the uptake of other 8 
screening tests, including those for cervical and breast cancer (White et al., 2009).  Whilst 9 
markers of low socio-economic position (SEP) have been associated with lower uptake of 10 
Down syndrome screening in France and the USA (Kuppermann et al., 2006, Khoshnood et 11 
al., 2003), such inequalities are not consistently reported in the UK, especially when key 12 
confounders, including maternal age, are controlled for (Alderdice et al., 2008, Rowe et al., 13 
2008, Rowe and Garcia, 2003).  However, most previous research has relied on maternal 14 
self-report of screening uptake, which may be subject to systematic socio-economic bias 15 
(Khoshnood et al., 2004). 16 
We used routine data from Northern England to explore the association between an area-17 
based marker of SEP and objectively measured uptake of Down Syndrome screening. 18 
The Northern Congenital Abnormality Survey (NorCAS) is a high quality, population-based 19 
register of congenital anomalies (Richmond and Atkins, 2005).  Since 1985, NorCAS has 20 
collected information on all cases of Down syndrome occurring to women resident in the 21 
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North East and North Cumbria .  From 2004, NorCAS has collected enhanced information on 1 
Down syndrome cases.   2 
Information on all Down syndrome affected pregnancies between 01 April 2004 and 31 3 
December 2009 was abstracted from the NorCAS database.  All diagnoses were confirmed 4 
by cytogenetics.  Pregnancies were excluded from the analysis if: structural fetal anomalies 5 
were diagnosed at the dating scan (8-12 weeks of gestation), an early miscarriage occurred 6 
before the first hospital antenatal visit had taken place, if the first hospital antenatal visit 7 
occurred outside of the study region or if the women was not eligible for screening (i.e. 8 
booked too late).  9 
Uptake of screening was defined as accepting any screening test in either the first or second 10 
trimester of pregnancy as recorded in maternal health records.  Socio-economic position 11 
was measured using the rank of the Index of Multiple Deprivation 2007 (IMD) score of the 12 
lower super output area of residence, identified from the postcode of maternal residence at 13 
the first hospital antenatal visit.  Index of Multiple Deprivation is an area-based marker of 14 
deprivation compiled from data across seven domains: income, employment, health 15 
deprivation and disability, education skills and training, barriers to housing and services, 16 
crime, and living environment (Noble et al., 2008).  Index of Multiple Deprivation ranks were 17 
collapsed into quintiles, based on scores across England and Wales as a whole, for analysis.  18 
Maternal age, defined as the age at termination or delivery, was modelled as a continuous 19 
variable. 20 
Differences in the distribution of maternal age between those who did and did not accept 21 
screening were investigated using the Mann-Whitney test.  Cuzick’s non-parametric test was 22 
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used to identify a potential trend in screening uptake across IMD quintiles.  Multivariate 1 
logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) 2 
corresponding to the in uptake of screening across IMD quintiles, before and after adjusting 3 
for maternal age.  All statistical analyses were performed using SPSS 17.0 and Stata 11. 4 
NorCAS is exempt from requiring consent for inclusion on the register under section 251 of 5 
the NHS Act 2006 and has ethics approval (09/H0405/08) to undertake studies involving the 6 
data. 7 
A total of 510 Down syndrome affected pregnancies were notified to NorCAS during the 8 
study period.  Following exclusions, 351 (68.8%) pregnancies remained.  All women with 9 
included pregnancies had been offered Down syndrome screening and 207 (59.0%) of these 10 
took up the offer.   11 
The median age of women who took up screening was 36 years (IQR: 30-39), compared with 12 
35 years (IQR: 28-39) in those who did not.  The distribution of age did not vary between 13 
women who accepted and declined screening (p=0.42).   14 
Table 1 shows the odds of uptake of Down syndrome screening by deprivation quintile.  15 
There was no significant trend differences in the uptake of screening across deprivation 16 
quintiles (p=0.23).  The odds of uptake in quintiles two to five did not vary significantly from 17 
the odds of uptake in quintile one (the most deprived group).  There was no evidence that 18 
screening uptake was associated with maternal age (Table 1).  Adjusting for age did not 19 
change the lack of association between deprivation and screening uptake.   20 
[Insert Table 1 here] 21 
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Amongst a group of women who had pregnancies that resulted in a diagnosis of Down 1 
syndrome in Northern England, we found no differences in uptake of NHS Down syndrome 2 
screening by SEP either before or after adjustment for maternal age.  Our use of 3 
prospectively recorded, objective measures of screening uptake represents a significant 4 
improvement on previous work that has relied on maternal self-report of screening uptake.  5 
These results confirm other UK data suggesting no evidence of socio-economic differences 6 
in uptake of Down syndrome screening (Alderdice et al., 2008, Rowe et al., 2008, Rowe and 7 
Garcia, 2003).  However, they contrast with findings from the USA and France which show 8 
strong socio-economic differences in Down syndrome screening uptake (Kuppermann et al., 9 
2006, Khoshnood et al., 2003). 10 
This study used data from a high quality regional congenital anomaly register which is 11 
known to have a high degree of completeness and accuracy (Richmond and Atkins, 2005).  12 
In particular, we used objectively and prospectively recorded information on uptake of 13 
Down syndrome screening.  Unlike previous work (Alderdice et al., 2008, Khoshnood et al., 14 
2003, Kuppermann et al., 2006, Rowe et al., 2008) we did not, therefore, have to rely on 15 
women’s retrospective self-report of whether or not they took up screening.   16 
We used IMD as a measure of SEP.  Whilst this is the UK government’s preferred measure of 17 
deprivation, and is therefore highly policy relevant, IMD scores are based on area level data.  18 
They, therefore, represent the average conditions of all individuals living in a small area, but 19 
do not necessarily represent the actual conditions of any one particular individual living in 20 
that area.  As individual-level markers of SEP (e.g. educational attainment, income, or 21 
occupation) are not held in the NorCAS database, IMD was the only marker of SEP available 22 
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to us.  Future work should explore differences in screening uptake according to other 1 
markers of SEP. 2 
Our data are restricted to Northern England and only pregnancies that resulted in a 3 
diagnosis of Down syndrome.  This may limit generalisability.  However, it is difficult to think 4 
of any reason why there might be systematic regional differences in socio-economic trends 5 
in uptake of screening across the UK or between pregnancies that did and did not result in a 6 
diagnosis of Down syndrome. 7 
Our data are restricted to information on Down syndrome screening within the NHS.  Thus 8 
information on screening that was obtained privately is not included in our dataset.  As 9 
private screening can entail substantial financial costs (around £100-200), more affluent 10 
women are likely to use private screening more often.  However, only 1% of pregnant 11 
women make use of private antenatal care/screening in the UK.  It is therefore unlikely that 12 
our exclusion of private screening significantly altered our results. 13 
Our results confirm previous findings suggesting no evidence of socio-economic differences 14 
in uptake of Down syndrome screening in the UK (Alderdice et al., 2008, Rowe et al., 2008, 15 
Rowe and Garcia, 2003).  Uptake of screening is related to, amongst other things, attitudes 16 
towards the screening test (Kuppermann et al., 2006, Li et al., 2008).  In the UK, attitudes 17 
towards the screening test are not related to SEP (Dormandy et al., 2005) and this may 18 
explain why there are no socio-economic differences in uptake.  Why attitudes to the test 19 
might be socio-economically patterned in some countries but not others is unclear. 20 
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Additionally, logistical difficulties with accessing the test in countries, such as the USA, 1 
where screening is not necessarily provided free at the point of delivery, may play a role in 2 
socio-economic differences in uptake in some countries, but not others. 3 
It is striking that socio-economic differences in uptake in some, but not all, screening tests 4 
have been reported in the UK.  This could be related to the procedures used to invite people 5 
for screening.  For example, Down syndrome screening is offered to all women in the UK 6 
during existing antenatal visits and no additional visit should be required.  This is quite 7 
different from the procedures used to invite women to, for example, cervical or breast 8 
cancer screening, where invitation letters offering an appointment or requesting that one is 9 
made are sent to women’s homes.  Further research should explore this more fully in order 10 
to ensure that health promotion programmes do not, inadvertently, lead to socio-economic 11 
inequalities in uptake and thus outcome. 12 
 13 
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Table 1: Uptake of the NHS Down Syndrome screening programme by deprivation quintile, North of England, 2004-09 
 Uptake of screening (n=351)     
Deprivation quintile 
Accepted 
(n=207); n (%) 
Declined  
(n=144); n (%) 
Unadjusted OR  
(95% CI) p-value 
Adjusted OR  
(95% CI)* p-value 
1 (most deprived) 72 (57.6) 53 (42.4) 1 -- 1 -- 
2 40 (54.1) 34 (45.9) 0.87 (0.49 to 1.54) 0.63 0.85 (0.47 to 1.52) 0.58 
3 40 (60.6) 26 (39.4) 1.13 (0.62 to 2.08) 0.69 1.10 (0.59 to 2.03) 0.77 
4 23 (59.0) 16 (41.0) 1.06 (0.51 to 2.20) 0.88 1.01 (0.48 to 2.13) 0.98 
5 (least deprived) 32 (68.1) 15 (31.9) 1.57 (0.77 to 3.19) 0.21 1.51 (0.74 to 3.11) 0.26 
Age (yrs), median (IQR) 36 (30-39) 35 (28-39) -- -- 1.01 (0.98 to 1.04) 0.57 
* Adjusted for maternal age 
 
